 | • レポートコード：C-GIR20G2897 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「神経内分泌腫瘍治療の世界市場2019年」は、グローバルにおける神経内分泌腫瘍治療市場を展望するレポートです。神経内分泌腫瘍治療のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・神経内分泌腫瘍治療の市場概観 ・神経内分泌腫瘍治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・神経内分泌腫瘍治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・神経内分泌腫瘍治療の世界市場規模 ・神経内分泌腫瘍治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・神経内分泌腫瘍治療のアメリカ市場規模推移 ・神経内分泌腫瘍治療のカナダ市場規模推移 ・神経内分泌腫瘍治療のメキシコ市場規模推移 ・神経内分泌腫瘍治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・神経内分泌腫瘍治療のドイツ市場規模推移 ・神経内分泌腫瘍治療のイギリス市場規模推移 ・神経内分泌腫瘍治療のロシア市場規模推移 ・神経内分泌腫瘍治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・神経内分泌腫瘍治療の日本市場規模推移 ・神経内分泌腫瘍治療の中国市場規模推移 ・神経内分泌腫瘍治療の韓国市場規模推移 ・神経内分泌腫瘍治療のインド市場規模推移 ・神経内分泌腫瘍治療の東南アジア市場規模推移 ・神経内分泌腫瘍治療の南米市場分析（ブラジル、アルゼンチン等） ・神経内分泌腫瘍治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・神経内分泌腫瘍治療の種類別分析/販売量、売上、市場シェア（エベロリムス、スニチニブ、Lu-Dotatate、ランレオタイド、オクトレオチド） ・神経内分泌腫瘍治療の用途別分析/市場規模（病院、診療所、その他） ・神経内分泌腫瘍治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・神経内分泌腫瘍治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Neuroendocrine Tumor Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuroendocrine Tumor Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Neuroendocrine Tumor Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuroendocrine Tumor Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Progenics Pharmaceuticals, Inc.
Tarveda Therapeutics
Hutchinson Medipharma Limited
Advanced Accelerator Applications
Exelixis, Inc.
Dauntless Pharmaceuticals, Inc.
Novartis AG
Ispen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Everolimus
Sunitinib
Lu-Dotatate
Lanreotide
Octreotide
Market Segment by Applications, can be divided into
Hospitals
Clinic
Others
Table of Contents
1 Neuroendocrine Tumor Treatment Market Overview
1.1 Product Overview and Scope of Neuroendocrine Tumor Treatment
1.2 Classification of Neuroendocrine Tumor Treatment by Types
1.2.1 Global Neuroendocrine Tumor Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Neuroendocrine Tumor Treatment Revenue Market Share by Types in 2018
1.2.3 Everolimus
1.2.4 Sunitinib
1.2.5 Lu-Dotatate
1.2.6 Lanreotide
1.2.7 Octreotide
1.3 Global Neuroendocrine Tumor Treatment Market by Application
1.3.1 Global Neuroendocrine Tumor Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Neuroendocrine Tumor Treatment Market by Regions
1.4.1 Global Neuroendocrine Tumor Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Neuroendocrine Tumor Treatment (2014-2024)
2 Company Profiles
2.1 Progenics Pharmaceuticals, Inc.
2.1.1 Business Overview
2.1.2 Neuroendocrine Tumor Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Tarveda Therapeutics
2.2.1 Business Overview
2.2.2 Neuroendocrine Tumor Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Hutchinson Medipharma Limited
2.3.1 Business Overview
2.3.2 Neuroendocrine Tumor Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Advanced Accelerator Applications
2.4.1 Business Overview
2.4.2 Neuroendocrine Tumor Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Exelixis, Inc.
2.5.1 Business Overview
2.5.2 Neuroendocrine Tumor Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Dauntless Pharmaceuticals, Inc.
2.6.1 Business Overview
2.6.2 Neuroendocrine Tumor Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis AG
2.7.1 Business Overview
2.7.2 Neuroendocrine Tumor Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis AG Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Ispen
2.8.1 Business Overview
2.8.2 Neuroendocrine Tumor Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ispen Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Neuroendocrine Tumor Treatment Market Competition, by Players
3.1 Global Neuroendocrine Tumor Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroendocrine Tumor Treatment Players Market Share
3.2.2 Top 10 Neuroendocrine Tumor Treatment Players Market Share
3.3 Market Competition Trend
4 Global Neuroendocrine Tumor Treatment Market Size by Regions
4.1 Global Neuroendocrine Tumor Treatment Revenue and Market Share by Regions
4.2 North America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
5 North America Neuroendocrine Tumor Treatment Revenue by Countries
5.1 North America Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
5.2 USA Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
6 Europe Neuroendocrine Tumor Treatment Revenue by Countries
6.1 Europe Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
6.2 Germany Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
6.4 France Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Neuroendocrine Tumor Treatment Revenue by Countries
7.1 Asia-Pacific Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
7.2 China Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
7.5 India Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
8 South America Neuroendocrine Tumor Treatment Revenue by Countries
8.1 South America Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
8.2 Brazil Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Neuroendocrine Tumor Treatment by Countries
9.1 Middle East and Africa Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
10 Global Neuroendocrine Tumor Treatment Market Segment by Type
10.1 Global Neuroendocrine Tumor Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Neuroendocrine Tumor Treatment Market Forecast by Type (2019-2024)
10.3 Everolimus Revenue Growth Rate (2014-2024)
10.4 Sunitinib Revenue Growth Rate (2014-2024)
10.5 Lu-Dotatate Revenue Growth Rate (2014-2024)
10.6 Lanreotide Revenue Growth Rate (2014-2024)
10.7 Octreotide Revenue Growth Rate (2014-2024)
11 Global Neuroendocrine Tumor Treatment Market Segment by Application
11.1 Global Neuroendocrine Tumor Treatment Revenue Market Share by Application (2014-2019)
11.2 Neuroendocrine Tumor Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Neuroendocrine Tumor Treatment Market Size Forecast (2019-2024)
12.1 Global Neuroendocrine Tumor Treatment Market Size Forecast (2019-2024)
12.2 Global Neuroendocrine Tumor Treatment Market Forecast by Regions (2019-2024)
12.3 North America Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
12.6 South America Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Neuroendocrine Tumor Treatment Picture
Table Product Specifications of Neuroendocrine Tumor Treatment
Table Global Neuroendocrine Tumor Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share by Types in 2018
Figure Everolimus Picture
Figure Sunitinib Picture
Figure Lu-Dotatate Picture
Figure Lanreotide Picture
Figure Octreotide Picture
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) by Application (2014-2024)
Figure Neuroendocrine Tumor Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinic Picture
Figure Others Picture
Table Global Market Neuroendocrine Tumor Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Progenics Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Type and Applications
Table Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Tarveda Therapeutics Basic Information, Manufacturing Base and Competitors
Table Tarveda Therapeutics Neuroendocrine Tumor Treatment Type and Applications
Table Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Hutchinson Medipharma Limited Basic Information, Manufacturing Base and Competitors
Table Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Type and Applications
Table Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table Advanced Accelerator Applications Neuroendocrine Tumor Treatment Type and Applications
Table Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Exelixis, Inc. Basic Information, Manufacturing Base and Competitors
Table Exelixis, Inc. Neuroendocrine Tumor Treatment Type and Applications
Table Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Dauntless Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Type and Applications
Table Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Neuroendocrine Tumor Treatment Type and Applications
Table Novartis AG Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Ispen Basic Information, Manufacturing Base and Competitors
Table Ispen Neuroendocrine Tumor Treatment Type and Applications
Table Ispen Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue Share by Players (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Players in 2017
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Neuroendocrine Tumor Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Neuroendocrine Tumor Treatment Revenue Market Share in 2018
Figure Global Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share by Regions in 2018
Figure North America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure South America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table North America Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
Table North America Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure USA Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table Europe Neuroendocrine Tumor Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure Germany Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure UK Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure France Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Neuroendocrine Tumor Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure China Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure India Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table South America Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
Table South America Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure Brazil Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Neuroendocrine Tumor Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue Share by Type (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Type (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Type in 2018
Table Global Neuroendocrine Tumor Treatment Revenue Forecast by Type (2019-2024)
Figure Global Neuroendocrine Tumor Treatment Market Share Forecast by Type (2019-2024)
Figure Global Everolimus Revenue Growth Rate (2014-2019)
Figure Global Sunitinib Revenue Growth Rate (2014-2019)
Figure Global Lu-Dotatate Revenue Growth Rate (2014-2019)
Figure Global Lanreotide Revenue Growth Rate (2014-2019)
Figure Global Octreotide Revenue Growth Rate (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue by Application (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue Share by Application (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Application (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Application in 2018
Table Global Neuroendocrine Tumor Treatment Revenue Forecast by Application (2019-2024)
Figure Global Neuroendocrine Tumor Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Figure Europe Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Figure South America Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
神経内分泌腫瘍治療薬市場：世界及び中国市場分析・予測（～2024年） Neuroendocrine Tumor Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Neuroendocrine Tumor Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Neuroendocrine Tum…- 脳腫瘍用治療市場：世界及び中国市場分析・予測（～2024年） Brain Tumor Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Brain Tumor Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Brain Tumor Treatment manu…
- 転移性骨腫瘍治療市場：世界及び中国市場分析・予測（～2024年） Metastatic Bone Tumor Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Metastatic Bone Tumor Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Metast…
- 神経内分泌がん市場：世界及び中国市場分析・予測（～2024年） Neuroendocrine Carcinoma Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Neuroendocrine Carcinoma industry with a focus on the Chinese market. The report provides key statistics on the market status of the Neuroendocrine Carci…
- 手術用腫瘍アブレーションの世界市場 2019年版：種類別（高周波焼、マイクロ波焼、凍結焼、その他）、用途別（肝臓がん、乳がん、肺癌、前立腺がん、その他） Scope of the Report: The global Surgical Tumor Ablation market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…